76Q-21664-29616
3 vaccinations
2 coded responses
28 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 605 / IL
- Registered
- 2021-02-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-05
Registered in v-safe
-
2021-02-05
Dose 1 — Pfizer-BioNTech
- 2021-02-05
- 2021-02-06
- 2021-02-07
- 2021-02-09
- 2021-02-10
- 2021-02-11
- 2021-02-19
-
2021-02-26
Dose 2 — Pfizer-BioNTech
- 2021-02-26
-
2021-02-27
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-28
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness · Headache, Fatigue or tirednessAdult check-in
-
2021-03-01
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection siteAdult check-in
- 2021-03-02
- 2021-03-03
- 2021-03-04
- 2021-03-05
- 2021-03-12
- 2021-03-19
- 2021-03-26
- 2021-04-02
- 2021-04-09
- 2021-05-29
- 2021-08-27
-
2021-08-31
Dose 3 — Pfizer-BioNTech
-
2021-10-01
Survey response — day 28, dose 3MedDRA: Headache — Feeling: GoodFree text: HeadachesMedDRA releases: 2024-11 · check-in free text available
- 2021-10-05
- 2021-10-12
- 2021-11-30
- 2022-03-03
-
2022-08-31
Survey response — 12 months, dose 3MedDRA: Brain fog, Mental disorder — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit, HospitalizationFree text: Foggy brain, mental health issuesMedDRA releases: 2024-11 · check-in free text available
-
2022-08-31
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-09-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-05 | Pfizer-BioNTech | |
| 2 | 2021-02-26 | Pfizer-BioNTech | |
| 3 | 2021-08-31 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-08-31 | Unsuccessful |
Free text
Release 9 — day 28, dose 3
Symptoms: Headaches
Release 12 — 12 months, dose 3
Symptoms: Foggy brain, mental health issues
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Brain fog | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Mental disorder | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release